Brief communication (Original). Correlation between liver signal intensity in hepatobiliary phase of Gd-EOB-DTPA enhancement and liver function reserves

1. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009; 39: 107-16.10.1111/j.1872-034X.2008.00441.x19208031Open DOISearch in Google Scholar

2. Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M. Liver functional reserve estimation: state of the art and relevance to local treatments. Oncology. 2010; 78: 131-4.10.1159/00031524120616595Open DOISearch in Google Scholar

3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31:864-71.10.1053/he.2000.585210733541Open DOISearch in Google Scholar

4. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut. 2003; 52:134-9.10.1136/gut.52.1.134177350912477775Open DOISearch in Google Scholar

5. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33:464-70.10.1053/jhep.2001.2217211172350Open DOISearch in Google Scholar

6. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd- EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology. 1995; 195:785-92.10.1148/radiology.195.3.77540117754011Search in Google Scholar

7. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology. 1996; 199:177-83.10.1148/radiology.199.1.86331438633143Search in Google Scholar

8. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology. 2005; 237: 89-98.10.1148/radiol.237103184216126918Search in Google Scholar

9. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, et al. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol. 2004; 5:231-9.10.3348/kjr.2004.5.4.231269816715637473Open DOISearch in Google Scholar

10. Tajima T, Takao H, Akai H, Kiryu S, Imamura H, Watanabe Y, et al. Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr. 2010; 34:362-6.10.1097/RCT.0b013e3181cd330420498536Search in Google Scholar

11. Katsube T, Okada M, Kumano S, Hori M, Imaoka I, Ishii K, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011; 46:277-83.10.1097/RLI.0b013e318200f67d21343827Open DOISearch in Google Scholar

12. Katsube T, Okada M, Kumano S, Imaoka I, Kagawa Y, Hori M, et al. Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. Eur J Radiol. 2012; 81:1460-4.10.1016/j.ejrad.2011.03.07321514080Open DOISearch in Google Scholar

13. Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011; 80:e311-6.10.1016/j.ejrad.2011.01.02021315529Open DOISearch in Google Scholar

14. Nakamura S, Awai K, Utsunomiya D, Namimoto T, Nakaura T, Morita K, et al. Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement? Jpn J Radiol. 2012; 30:25-33.Search in Google Scholar

15. Verloh N, Haimerl M, Zeman F, Schlabeck M, Wiggermann P, et al. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol. 2014; 24:1013-9.10.1007/s00330-014-3108-y24531844Open DOISearch in Google Scholar